Ligand-induced STAT3 signaling increases at relapse and is associated with outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
Alexandra M Stevens, Marcos J Ruiz, Robert B Gerbing, Todd A Alonzo, Alan S Gamis, Michele S Redell
Article in Haematologica, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
6 authors.
Alexandra M StevensDivision of Pediatric Hematology/Oncology, Baylor College of Medicine, Houston, TX, USA amsteven@txch.org.
Marcos J RuizDivision of Pediatric Hematology/Oncology, Baylor College of Medicine, Houston, TX, USA.
Robert B GerbingChildren's Oncology Group, Monrovia, CA, USA.
Todd A AlonzoDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA, USA.
Alan S GamisChildren's Mercy Hospitals and Clinics, Kansas City, MO, USA.
Michele S RedellDivision of Pediatric Hematology/Oncology, Baylor College of Medicine, Houston, TX, USA.
Funding
COG SDMC - Statistics CoreU10CA180899 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TODD A ALONZO · 2014 to 2026
$132.8M
Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Michael M Ittmann · 2007 to 2026
$73.9M
Virology CoreP30AI036211 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI BUTEL, JANET S · 1994 to 2015
$21.7M
PEDIATRIC ONCOLOGY CLINICAL RESEARCH TRAINING PROGRAMK12CA090433 · NCI · BAYLOR COLLEGE OF MEDICINE · PI CARL E ALLEN, Donald W. Parsons · 2002 to 2026
$18.5M
Support for Human Specimen Banking in NCI-Supported Cancer Clinical TrialsU24CA114766 · NCI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI RAMIREZ MILAN, NILSA DEL CARMEN · 2005 to 2014
$14.5M
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AMLR01CA175026 · NCI · BAYLOR COLLEGE OF MEDICINE · PI REDELL, MICHELE S. · 2014 to 2018
$2.0M
Stat3 Isoforms in Maturation and Survival of Normal and Malignant Myeloid CellsK08HL085018 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI REDELL, MICHELE S. · 2008 to 2012
$641k
BD Biosciences Special Order LSRIIS10RR024574 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI LUMPKIN, ELLEN A · 2009 to 2009
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Ligand-induced STAT3 signaling increases at relapse and is associated with outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group. · full record | OpenQuestion